Scientific Secrecy and “Spin”: The Sad, Sleazy Saga of the Trials of Remune.

Part of a special issue on sequestered science and the consequences of undisclosed knowledge. The writer discusses the legal clash between researchers and their sponsors over disclosure of the findings of the clinical trials of Remune, an AIDS therapy developed by California biotech company Immune...

Full description

Bibliographic Details
Published in:Law & Contemporary Problems Vol. 69; no. 3; pp. 47 - 68
Main Author: Haack, Susan
Format: Article
Published: Duke University Summer2006
Subjects:
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=502512659&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 502512659
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00239186
        LCP
      jtl: Law & Contemporary Problems
      issn: 00239186
      maglogo: N
    pubinfo:
      dt: Summer2006
      vid: 69
      iid: 3
      pid: 588
      pub: Duke University
    artinfo:
      ui: 502512659
      ppf: 47
      ppct: 21
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
              size: 1.5MB
      tig:
        atl: Scientific Secrecy and “Spin”: The Sad, Sleazy Saga of the Trials of Remune.
      aug:
        au: Haack, Susan
      su:
        Clinical drug trials
        AIDS treatment
        Universities & colleges
        Business & education
        Pharmaceutical research
        United States
      sug:
        subj:
          United States
          Clinical drug trials
          AIDS treatment
          Universities & colleges
          Business & education
          Pharmaceutical research
      keyword: Immune Response Corporation -- Research and development
      ab: Part of a special issue on sequestered science and the consequences of undisclosed knowledge. The writer discusses the legal clash between researchers and their sponsors over disclosure of the findings of the clinical trials of Remune, an AIDS therapy developed by California biotech company Immune Response Corporation. She presents an outline of what science is and does that implies how and why the manner in which scientific work is funded can distort or even impede its progress. She applies this theory to an analysis of the troubled history of the trials, clinical and legal, of Remune. Finally, she offers some thoughts on industrial sponsorship of scientific research in the universities.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N